Related Experiment Video
Updated: Aug 26, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Pulmonary function in bronchopulmonary dysplasia
Beverley Robin1, Young-Jee Kim, Jaimee Huth
1Department of Pediatrics, University of Chicago Children's Hospital, University of Chicago, Chicago, Illinois, USA.
Insights
Infants with bronchopulmonary dysplasia (BPD) show reduced airflow and air trapping. Some infants with BPD also demonstrate significant bronchodilator responsiveness, especially those with recurrent wheezing.
Area of Science:
- Pediatric Pulmonology
- Neonatology
- Respiratory Medicine
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting preterm infants.
- Prematurity and BPD can lead to long-term pulmonary function abnormalities.
- Assessing lung function in infants with BPD is crucial for understanding disease progression and management.
Purpose of the Study:
- To evaluate lung function and bronchodilator responsiveness in infants with a history of prematurity and BPD.
- To compare pulmonary function parameters between infants with and without BPD.
- To investigate the impact of recurrent wheezing on airway dysfunction in infants with BPD.
Main Methods:
- Utilized raised volume rapid thoracoabdominal compression and whole-body plethysmography for spirometry.
- Measured fractional lung volumes, forced expiratory flows (FEV0.5, FEF75, FEF25-75), and lung volumes (FRC, RV, TLC).
- Assessed bronchodilator responsiveness by administering albuterol and re-measuring parameters.
Main Results:
- Infants with BPD history showed decreased forced expiratory flows (P<0.01) and increased residual volume (RV) and RV/TLC (P<0.05) compared to controls.
- No significant difference in total lung capacity (TLC) was observed between groups.
- 35% of infants demonstrated significant bronchodilator responsiveness; those with wheezing had more severe airway dysfunction.
Conclusions:
- Infants with BPD exhibit pulmonary function abnormalities, including mild-to-moderate airflow obstruction and air trapping.
- Hyperinflation and expiratory flow limitation are characteristic findings in this population.
- Airway responsiveness is more pronounced in infants with recurrent wheezing, suggesting distinct pathophysiological mechanisms.
Abstract:
The purpose of this study was to examine lung function and bronchodilator responsiveness in infants with a history of prematurity and bronchopulmonary dysplasia (BPD), using the raised volume rapid thoracoabdominal compression technique as well as with whole-body plethysmography. Spirometric measurements were obtained in 28 infants with a history of BPD, defined as preterm birth with O2 requirement at 36 weeks postmenstrual age (gestational age at birth, 26.4 +/- 2.1 weeks, mean +/- SD; birthweight, 898 +/- 353 g; age at study, 68.0 +/- 35.6 weeks). Fractional lung volumes were measured in 27 subjects. Values were expressed as percentage of predicted normal values. Compared to normal infants, those with a history of BPD exhibited decreases in forced expiratory flows including forced expiratory volume in 0.5 sec (76.3 +/- 19.6%), forced expiratory flow at 75% of expired forced vital capacity (FEF75; 59.5 +/- 30.7%), and FEF(25-75) (74.0 +/- 26.8%; P<0.01 for all). Functional residual capacity (107.9 +/- 25.3%), residual volume (RV, 124.5 +/- 42.7%), and RV/total lung capacity (RV/TLC, 128.2 +/- 35.3%) were increased in infants with a history of BPD (P<0.05 for each). There was no difference in TLC between groups. Seventeen infants were studied both pre- and postalbuterol, and 6 (35%) demonstrated significant bronchodilator responsiveness. Infants with recurrent wheezing showed greater expiratory flow limitation, hyperinflation, and airways responsiveness, whereas those without wheezing showed only modest airway dysfunction. We conclude that infants with a history of BPD have pulmonary function abnormalities characterized by mild to moderate airflow obstruction and air trapping.
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation